Stocks
Alnylam Pharmaceuticals, Inc.ALNY
NASDAQHealthcareBiotechnology$313.41-1.20%
A biotechnology company focused on developing RNA interference (RNAi) therapeutics that silence disease-causing genes. Its approved drugs target rare genetic conditions, including hereditary transthyretin-mediated amyloidosis, while a broader pipeline spans cardiometabolic, hepatic, and neurologic d...
Market Cap: $41.6B52W Range: $205.87 – $495.55
This page tracks all publicly disclosed congressional trades in Alnylam Pharmaceuticals, Inc. (ALNY), a company in the Healthcare sector. 4 members of Congress have disclosed trades in this stock, including 8 purchases and 8 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
16
Unique Politicians
4
Buys
8
Sells
8
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2024-01-29 | Josh Gottheimer | sell | $1K – $15K |
| 2024-01-11 | Josh Gottheimer | buy | $1K – $15K |